权益分类	功能权益	普通用户	{{item.name}}会员
{{category.name}}	{{benefitItem.name}}

Effector T-cell trafficking in graft-versus-host disease

移植物抗宿主病中的效应 T 细胞运输

基本信息

批准号：
10443805
负责人：
Ran Reshef
金额：
$ 40.5万
依托单位：
COLUMBIA UNIVERSITY HEALTH SCIENCES
依托单位国家：
美国
项目类别：
财政年份：
2019
资助国家：
美国
起止时间：
2019-08-01 至 2024-06-30
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/10443805
关键词：
Acute Graft Versus Host Disease Affect Allogenic Busulfan CCR5 gene CXC chemokine receptor 3 CXCR3 gene Cell Migration Pathway Cells Chemotaxis Clinical Clinical Data Clinical Trials Data Data Set Development Disease Disease model Enrollment Environment Failure Gastrointestinal tract structure Genetic Genomics Goals Hematopoietic Stem Cell Transplantation Homing Human Immune response Immunologic Memory Immunologics In Situ Individual Infection Inflammatory Investigation Knock-out Knowledge Lead Ligands Lymphocyte Mediating Melphalan Memory Methodology Modeling Morbidity - disease rate Multicenter Trials Mus Organ Outcome PPBP gene Pathogenesis Pathogenicity Pathway interactions Patients Pharmacology Phenotype Prevention Prevention strategy Property Prophylactic treatment Receptor Signaling Recurrent disease Regimen Resistance Role STAT3 gene Serum Shapes Side Signal Transduction Stem cell transplant T memory cell T-Lymphocyte Technology Testing Therapeutic Tissues Transplant Recipients Transplantation Transplantation Conditioning antagonist base cell motility chemokine chemokine receptor clinically relevant conditioning effector T cell experimental study genomic data graft vs host disease graft vs leukemia effect inflammatory milieu inhibitor migration mortality mouse model novel novel strategies pre-clinical prevent protective effect receptor relapse risk resistance mechanism response single cell analysis single cell technology success therapeutic target therapy resistant trafficking translational approach translational study

项目摘要

Project Abstract Blockade of lymphocyte chemotaxis is a promising strategy for the prevention of graft-versus-host disease (GvHD) following allogeneic hematopoietic stem-cell transplantation (alloHSCT). Specifically, blockade of the chemokine receptor CCR5 has so far been examined in several clinical trials and clinical results appear promising, showing low rates of acute GvHD without an increase in relapse risk or infectious complications. However, prophylaxis failure still occurred in some patients and data in humans and murine suggest that signaling through CXCR3 serves as a resistance mechanism. Dual CCR5/CXCR3 blockade is a potential strategy, but a detailed understanding of chemokine receptor signaling in alloreactive T-cell migration is needed first. We propose to study the individual roles of CCR5 and CXCR3 in T-cell migration into target organs and the impact of potential blocking strategies. The central hypothesis of this proposal is that CCR5 and CXCR3 are complementary pathways in alloreactive T-cell migration and that combined blockade of both receptors will lead to greater protection against GvHD compared to single-receptor blockade. In support of this hypothesis, we show preliminary data that demonstrate distinct functional properties for CCR5-and CXCR3-expressing T- cells in GvHD, evidence for CXCR3 operating as a resistance mechanism to CCR5 blockade and evidence that CCR5 and CXCR3 ligands activate T-cells through STAT3 independent of their effect on T-cell navigation. To test this hypothesis, we will use murine models and clinical data and biospecimens from 167 patients enrolled on 3 clinical trials to examine the relationship between CCR5 and CXCR3 in GvHD. In Aim 1, we will identify the resistance mechanisms to CCR5 blockade in alloHSCT recipients and identify a novel role for conditioning agents in modulating the role of chemokine receptors in GvHD. In Aim 2, we will determine the complementary roles of CCR5 and CXCR3 in tissue-infiltrating alloreactive T-cells using a novel single-cell methodology in mice and humans. This technology will allow us to assess the potential role of additional chemokine receptors and homing molecules. Aim 3 will examine the impact of dual CCR5/CXCR3 blockade approach on the graft-versus-host and graft-versus-leukemia responses in mouse models. This translational study will fuel our mechanistic understanding of T-cell migration in GvHD, and enable the development of a strategy of combined receptor blockade in humans.

项目摘要